SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 22, 2007  
 
StatSure Diagnostic Systems, Inc.

(Exact name of Registrant as specified in its charter)    

Delaware

(State or other jurisdiction of incorporation)
 
 
 
 
 
000-21284
 
 
 
91-1549305
(Commission
 
 
 
(IRS Employer
File Number)
 
 
 
Identification No.)
 
 
 
 
 
1881 Worcester Rd.  #200, Framingham, MA.
 
01701
(Address of principal executive offices)
 
(Zip Code)
 
508.872.2625

(Registrant’s telephone number, including area code)
Saliva Diagnostic Systems, Inc.
 

(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

ITEM 7.01.  Regulation FD Disclosures.

On November 5, 2007, the Company issued the press release titled “ StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA ” included herein as Exhibit 99.1.


In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing. This Current Report on Form 8-K does not constitute a determination of whether any information included herein is material.

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Saliva Diagnostic Systems, Inc.
 
Date: November 8, 2007
By:  
/s/ Steven Peltzman  
 
 
Steven Peltzman  
 
 
Chief Executive Officer 
 
 
 

 
StatSure Diagnostic Syst... (CE) (USOTC:SSUR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 StatSure Diagnostic Syst... (CE) 차트를 더 보려면 여기를 클릭.
StatSure Diagnostic Syst... (CE) (USOTC:SSUR)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 StatSure Diagnostic Syst... (CE) 차트를 더 보려면 여기를 클릭.